SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-17-012575
Filing Date
2017-07-13
Accepted
2017-07-13 15:47:51
Documents
2
Period of Report
2017-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1315
2 ruffolopoa.htm EX-24 10208
  Complete submission text file 0001437749-17-012575.txt   13070
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
RUFFOLO ROBERT R (Reporting) CIK: 0001187308 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37942 | Film No.: 17963525